Literature DB >> 2506101

Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease.

H Aiges1, J Markowitz, J Rosa, F Daum.   

Abstract

We hypothesized that supplemental nutritional support delivered at home by nocturnal nasogastric feedings would result in accelerated growth in growth-retarded adolescents with Crohn's disease. Eight Tanner stage I adolescents with Crohn's disease, mean age 14 yr 5 mo, had a mean weight gain of 0.38 kg and height gain of 1.4 cm for the year before initiation of nasogastric feedings. All had been either asymptomatic or had only minimal symptoms in the year before the study, but were ingesting only 55%-80% of their daily required caloric intake. The subjects were taught to pass by themselves a nasogastric feeding tube, through which 1000-1500 ml of commercial, nonelemental isocaloric formula was infused during sleep to supplement their usual dietary intake. After 12 mo of nocturnal feedings, the subjects had a mean weight gain of 11.75 kg and a mean height gain of 6.98 cm. Six control subjects, matched for age and degree of growth and sexual retardation at the beginning of the study period, but who had refused the nasogastric feedings, had no change in weight and height during the same period of observation. We conclude that home nocturnal nasogastric feedings can achieve dramatic improvement in weight gain and linear growth in motivated adolescents with Crohn's disease and growth retardation.

Entities:  

Mesh:

Year:  1989        PMID: 2506101     DOI: 10.1016/0016-5085(89)91496-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  21 in total

1.  Divergency of leptin response in intestinal inflammation.

Authors:  A Ballinger
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 2.  Nutrition in Crohn's disease.

Authors:  J E Lennard-Jones
Journal:  Ann R Coll Surg Engl       Date:  1990-05       Impact factor: 1.891

Review 3.  Chronic inflammatory bowel disease.

Authors:  I W Booth
Journal:  Arch Dis Child       Date:  1991-06       Impact factor: 3.791

Review 4.  Conventional therapy for Crohn's disease.

Authors:  Carsten Büning; Herbert Lochs
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

5.  Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone.

Authors:  M Azcue; M Rashid; A Griffiths; P B Pencharz
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

6.  Parenteral and enteral nutrition in gastrointestinal disease.

Authors:  A G Thomas
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

Review 7.  Chronic inflammatory bowel disease.

Authors:  N K Mittal; B S Kirschner
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

8.  Growth and clinical course of children with Crohn's disease.

Authors:  A M Griffiths; P Nguyen; C Smith; J H MacMillan; P M Sherman
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

9.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

Review 10.  Mechanisms of growth impairment in pediatric Crohn's disease.

Authors:  Thomas D Walters; Anne M Griffiths
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-09       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.